MetaCap

Cel-Sci (CVM) vs Genenta Science S.p.A. (SAEN)

Head-to-head comparison of performance, valuation, growth, profitability and dividends. Prices delayed 15 minutes; data as of Nov 22, 2026.

Summary

Genenta Science S.p.A. is the larger company by market cap ($24.5 million vs $21.3 million), about 1.1 times the size.

Summary generated from market data by MetaCap's automated system. Methodology

Relative performance

CVM-14.18%SAEN-47.19%
+35%-8%-51%
Nov 3, 20261 yearNov 20, 2026
CVM-16.55%SAEN-23.70%
+1%-12%-25%
Nov 2, 20265 yearsNov 16, 2026

Percent change in share price from the first common trading day shown; excludes dividends.

Head-to-head

CVM versus SAEN key metrics
MetricCVMSAEN
Share price$1.21$0.5074
Market cap$21.28M$24.47M
1-day change-17.69%-9.39%
YTD return-77.00%—
1-year return-80.67%—
5-year return-99.61%—
EPS (TTM)$-1.69$-0.37
Dividend yield0.00%0.00%
Annual dividend$0.00$0.00
Net income (latest FY)$-25.41M—
52-week high$7.80$2.58
52-week low$0.89$0.50
Distance from 52-week high-84.49%-80.33%
Analyst consensusnone—
Avg. price target upside+933.06%—
Average volume231.46K85.01K
Shares outstanding17.59M48.22M
Employees—9
SectorHealth CareHealth Care
IndustryBiotechnology: Biological Products (No Diagnostic Substances)Biotechnology: Biological Products (No Diagnostic Substances)

Highlighted cells mark the higher value for growth, returns, margins and yield, and the lower value for P/E ratios. Highlighting is a mechanical comparison, not a recommendation.

About Cel-Sci

CVM stock →

CEL-SCI Corporation, a clinical-stage biotechnology company, engages in the research and development to treat cancer and other diseases by using the immune system in the United States. The company's lead immunotherapy is Multikine, which has completed Phase III clinical trials for the potential treatment of certain head and neck cancers.

Health Care · Biotechnology: Biological Products (No Diagnostic Substances)

About Genenta Science S.p.A.

SAEN stock →

Genenta Science S.p.A. operates as a strategic consolidator that focuses on acquiring ownership of privately held companies operating in Italian national-security-regulated sectors.

Health Care · Biotechnology: Biological Products (No Diagnostic Substances) · 9 employees

CVM vs SAEN FAQ

Which is bigger, Cel-Sci or Genenta Science S.p.A.?

Genenta Science S.p.A. (SAEN) is larger, with a market capitalization of $24.47M compared with $21.28M for Cel-Sci (CVM).

Are Cel-Sci and Genenta Science S.p.A. in the same industry?

Yes. Both are classified in the Biotechnology: Biological Products (No Diagnostic Substances) industry within the Health Care sector.

More comparisons